Next Article in Journal
Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
Previous Article in Journal
Overcoming Challenges in Pediatric Formulation with a Patient-Centric Design Approach: A Proof-of-Concept Study on the Design of an Oral Solution of a Bitter Drug
Previous Article in Special Issue
Dehydrocrenatidine Induces Liver Cancer Cell Apoptosis by Suppressing JNK-Mediated Signaling
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(11), 1332; https://doi.org/10.3390/ph15111332
Action Date Notes Link
article xml file uploaded 28 October 2022 09:59 CEST Original file -
article xml uploaded. 28 October 2022 09:59 CEST Update -
article pdf uploaded. 28 October 2022 10:00 CEST Version of Record -
article supplementary file uploaded. 28 October 2022 10:00 CEST - https://www.mdpi.com/1424-8247/15/11/1332#supplementary
article html file updated 28 October 2022 10:01 CEST Original file -
article html file updated 28 October 2022 10:02 CEST Update -
article xml file uploaded 28 October 2022 11:49 CEST Update -
article xml uploaded. 28 October 2022 11:49 CEST Update https://www.mdpi.com/1424-8247/15/11/1332/xml
article pdf uploaded. 28 October 2022 11:49 CEST Updated version of record https://www.mdpi.com/1424-8247/15/11/1332/pdf
article html file updated 28 October 2022 11:50 CEST Update -
article html file updated 2 March 2023 01:06 CET Update https://www.mdpi.com/1424-8247/15/11/1332/html
Back to TopTop